NNBR:NASDAQNN, Inc. Analysis
Data as of 2026-05-22 - not real-time
$2.42
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Technical momentum shift: the 20‑day moving average now sits above the 50‑day and 200‑day averages, indicating bullish pressure. The Relative Strength Index is in the mid‑fifties, suggesting a neutral stance. The MACD histogram remains negative with a bearish signal line, hinting at short‑term downside risk. Trading volume is decreasing, which may temper price moves. The stock is testing a clear support zone that aligns with recent lows. Earnings surprise: the company posted a modest profit per share that far exceeded analyst expectations, driving the share price up more than 30% after the release. Management reported double‑digit year‑over‑year revenue growth across both business segments. Forward guidance shows earnings per share moving from a loss to a modest positive outlook.
Valuation metrics show a current price‑to‑earnings ratio effectively at zero due to losses, while the forward PE is well below the industry average, suggesting the market may be undervaluing the turnaround. The price‑to‑book ratio is elevated, reflecting penny‑stock pricing pressure, yet analyst upside estimates exceed 100%, reinforcing an undervalued view. The balance sheet is a concern, with debt far outweighing equity and negative free cash flow. A beta markedly above the market and 30‑day volatility over one‑hundred percent create a high risk profile. Despite these risks, the earnings beat, revenue growth, and attractive forward valuation provide a compelling case for a measured entry for risk‑tolerant investors.
Valuation metrics show a current price‑to‑earnings ratio effectively at zero due to losses, while the forward PE is well below the industry average, suggesting the market may be undervaluing the turnaround. The price‑to‑book ratio is elevated, reflecting penny‑stock pricing pressure, yet analyst upside estimates exceed 100%, reinforcing an undervalued view. The balance sheet is a concern, with debt far outweighing equity and negative free cash flow. A beta markedly above the market and 30‑day volatility over one‑hundred percent create a high risk profile. Despite these risks, the earnings beat, revenue growth, and attractive forward valuation provide a compelling case for a measured entry for risk‑tolerant investors.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- earnings surprise
- bullish SMA crossover
- support level
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- revenue growth
- forward PE advantage
- upside potential
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- high debt load
- negative free cash flow
- industry exposure
Key Metrics & Analysis
Financial Health
Revenue Growth12.10%
Profit Margin-7.85%
P/E Ratio11.0
ROE-21.84%
ROA-2.10%
Debt/Equity151.93
P/B Ratio4.9
Op. Cash Flow$395.0K
Free Cash Flow$-351750
Industry P/E29.5
Technical Analysis
TrendBullish
RSI55.7
Support$2.10
Resistance$2.99
MA 20$2.43
MA 50$1.97
MA 200$1.79
MACDBearish
VolumeDecreasing
Fear & Greed Index91.09
Valuation
Target Price$5.50
Upside/Downside127.27%
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.82
Volatility110.07%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.